Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy

Haematologica. 2011 Mar;96(3):e15; author reply e16-7. doi: 10.3324/haematol.2011.040048.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Dasatinib
  • Diuretics / administration & dosage
  • Drug Administration Schedule
  • Female
  • Furosemide / administration & dosage
  • Glucocorticoids / administration & dosage
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / physiopathology
  • Male
  • Middle Aged
  • Pericardial Effusion / chemically induced*
  • Pericardial Effusion / drug therapy
  • Pleural Effusion / chemically induced*
  • Pleural Effusion / drug therapy
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / adverse effects
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*
  • Risk Factors
  • Severity of Illness Index
  • Thiazoles / administration & dosage
  • Thiazoles / adverse effects*
  • Turkey

Substances

  • Diuretics
  • Glucocorticoids
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Furosemide
  • Protein-Tyrosine Kinases
  • Dasatinib